What the research found
Heart rate variability—the millisecond-to-millisecond fluctuations in your heartbeat—reflects activity in your autonomic nervous system and has been linked for decades to cardiovascular and all-cause mortality risk in clinical studies. However, those studies measured HRV directly via electrocardiogram (ECG). Consumer wearables don't do this. Instead, they estimate variability from optical pulse sensors (the light you see flashing on your wrist) or mechanical mattress sensors, which measure something technically different called pulse rate variability (PRV) or mechanical pulse variability (MPV). These aren't equivalent to ECG-derived HRV, especially during movement or activity.
The measurement problem runs deeper. Different wearables use different mathematical formulas to quantify variability—some use SDNN (Apple's choice), others use RMSSD (more widely validated)—and measure over different timeframes (minutes, all day, or overnight). Short measurements are unreliable because they don't capture enough of the natural rhythms that influence HRV. When researchers compare readings from different wearables on the same person on the same day, the results often diverge substantially in patterns and absolute numbers.
The validation gap is substantial. Most independent studies comparing wearable PRV to true ECG-derived HRV are small, conducted only in young healthy adults, and show reasonable but imperfect correlation. Crucially, in a larger real-world study of over 900 adults with chronic diseases, PRV from wearables was found to be poorly correlated with ECG HRV and systematically underestimated across multiple disease states—leading researchers to conclude wearable readings are "an invalid surrogate" for actual HRV in this population.
Why it matters for you
If you're using HRV or "Readiness" scores from your wearable to guide training load, sleep prioritization, or supplement timing, you're working with a signal that may not reflect what you think it does. The biomarker you're tracking isn't standardized across devices—your Apple Watch, Oura ring, and Fitbit may tell you contradictory stories about the same night's recovery. This matters because decisions based on noise look like personalization but are actually noise.
The real issue: there's no proven causal link between raising your wearable HRV and actually improving health outcomes. The clinical associations between low HRV and mortality came from ECG data in hospital populations. Assuming that boosting your optical pulse variability will lower disease risk is a leap not supported by evidence. You might be optimizing for a metric rather than for recovery, training tolerance, or longevity itself.
For users tracking peptides, TRT, or sleep interventions, this means wearable HRV should be treated as one noisy signal among many—not as a validated biomarker of autonomic health. Blood work, training performance, subjective recovery, and sleep architecture remain more grounded. If your wearable's readiness score doesn't match how you actually feel or your objective performance, that's not a bug worth fixing; it's a feature of a still-unvalidated composite metric.
Caveats
- Validation studies are mostly small and in healthy young adults—findings may not generalise to older people or those with chronic disease, where PRV performance actually degrades.
- No causal evidence—low HRV is associated with poor outcomes, but raising HRV hasn't been shown to improve them.
- Measurement non-standardization—different wearables use different math, different sensors, and different sampling windows, making cross-device comparison unreliable.
- Underrepresentation in research—people of color, those with obesity or underweight frames, and older adults are understudied; PPG optical sensors are known to perform worse in darker skin tones.
- Most wearables lack independent validation—manufacturers publish correlations but independent peer-reviewed studies are sparse.